Cargando…

Antimicrobial Stewardship Programs: How to Start and Steer a Successful Program

BACKGROUND: Antimicrobial stewardship programs (ASPs) promote the appropriate use of antimicrobials by selecting the appropriate dose, duration,and route of administration. The appropriate use of antimicrobials has the potential to improve efficacy, reduce treatment-related costs, minimize drug-rela...

Descripción completa

Detalles Bibliográficos
Autor principal: Drew, Richard H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2009
Materias:
Cea
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437655/
https://www.ncbi.nlm.nih.gov/pubmed/19236137
http://dx.doi.org/10.18553/jmcp.2009.15.s2.18
_version_ 1785092580813307904
author Drew, Richard H.
author_facet Drew, Richard H.
author_sort Drew, Richard H.
collection PubMed
description BACKGROUND: Antimicrobial stewardship programs (ASPs) promote the appropriate use of antimicrobials by selecting the appropriate dose, duration,and route of administration. The appropriate use of antimicrobials has the potential to improve efficacy, reduce treatment-related costs, minimize drug-related adverse events, and limit the potential for emergence of antimicrobial resistance. OBJECTIVES: To summarize ASP tactics that can improve the appropriate use of antimicrobials in the hospital setting. Several measures can be used to implement such programs and gain multidisciplinary support while addressing common barriers. SUMMARY: Implementation of an ASP requires a multidisciplinary approach with an infectious diseases physician and a clinical pharmacist with infectious diseases training as its core team members. As identified by recently published guidelines, 2 proactive strategies for promoting antimicrobial stewardship include: (1) formulary restriction and pre-authorization, and(2) prospective audit with intervention and feedback. Other supplemental strategies involve education, guidelines and clinical pathways, antimicrobial order forms, de-escalation of therapy, intravenous-to-oral (IV-to-PO) switch therapy, and dose optimization. Several barriers exist to successful implementation of ASPs. These include obtaining adequate administrative support and compensation for team members. Gaining physician acceptance can also be challenging if there is a perceived loss of autonomy in clinical decision making. CONCLUSIONS: ASPs have the potential to reduce antimicrobial resistance,health care costs, and drug-related adverse events while improving clinical outcomes. The efforts and expense required to implement and maintain ASPs are more than justified given their potential benefits to both the hospital and the patient.
format Online
Article
Text
id pubmed-10437655
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-104376552023-08-21 Antimicrobial Stewardship Programs: How to Start and Steer a Successful Program Drew, Richard H. J Manag Care Pharm Cea BACKGROUND: Antimicrobial stewardship programs (ASPs) promote the appropriate use of antimicrobials by selecting the appropriate dose, duration,and route of administration. The appropriate use of antimicrobials has the potential to improve efficacy, reduce treatment-related costs, minimize drug-related adverse events, and limit the potential for emergence of antimicrobial resistance. OBJECTIVES: To summarize ASP tactics that can improve the appropriate use of antimicrobials in the hospital setting. Several measures can be used to implement such programs and gain multidisciplinary support while addressing common barriers. SUMMARY: Implementation of an ASP requires a multidisciplinary approach with an infectious diseases physician and a clinical pharmacist with infectious diseases training as its core team members. As identified by recently published guidelines, 2 proactive strategies for promoting antimicrobial stewardship include: (1) formulary restriction and pre-authorization, and(2) prospective audit with intervention and feedback. Other supplemental strategies involve education, guidelines and clinical pathways, antimicrobial order forms, de-escalation of therapy, intravenous-to-oral (IV-to-PO) switch therapy, and dose optimization. Several barriers exist to successful implementation of ASPs. These include obtaining adequate administrative support and compensation for team members. Gaining physician acceptance can also be challenging if there is a perceived loss of autonomy in clinical decision making. CONCLUSIONS: ASPs have the potential to reduce antimicrobial resistance,health care costs, and drug-related adverse events while improving clinical outcomes. The efforts and expense required to implement and maintain ASPs are more than justified given their potential benefits to both the hospital and the patient. Academy of Managed Care Pharmacy 2009-03 /pmc/articles/PMC10437655/ /pubmed/19236137 http://dx.doi.org/10.18553/jmcp.2009.15.s2.18 Text en Copyright © 2009, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Cea
Drew, Richard H.
Antimicrobial Stewardship Programs: How to Start and Steer a Successful Program
title Antimicrobial Stewardship Programs: How to Start and Steer a Successful Program
title_full Antimicrobial Stewardship Programs: How to Start and Steer a Successful Program
title_fullStr Antimicrobial Stewardship Programs: How to Start and Steer a Successful Program
title_full_unstemmed Antimicrobial Stewardship Programs: How to Start and Steer a Successful Program
title_short Antimicrobial Stewardship Programs: How to Start and Steer a Successful Program
title_sort antimicrobial stewardship programs: how to start and steer a successful program
topic Cea
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437655/
https://www.ncbi.nlm.nih.gov/pubmed/19236137
http://dx.doi.org/10.18553/jmcp.2009.15.s2.18
work_keys_str_mv AT drewrichardh antimicrobialstewardshipprogramshowtostartandsteerasuccessfulprogram